Research Peptide Fundamentals research peptides: a plain-English map

The short version

Peptide Download is a reading desk, not a store. It covers Research Peptide Fundamentals — the basics of four peptides that show up constantly in research, clinical, and wellness conversations: BPC-157, Ipamorelin, Semaglutide, and GHK-Cu.

A peptide is simply a short chain of amino acids, the same building blocks proteins are made from. Because they are small and chemically specific, peptides can fit particular receptors on cells and switch processes on or off. These four were chosen because they approach some of the most active areas of current research — tissue repair, growth-hormone signaling, metabolism and weight, and skin regeneration — from four very different angles.

This guide tells you, in plain language and with numbered citations, what each peptide was actually studied on, in which species, and how solid the evidence really is. Some of these compounds have large, replicated human trials behind them. Others are almost entirely preclinical. We keep that distinction visible on every page. We do not sell anything, and we never give medical advice or list a human dose.

What are research peptides?

Every protein in your body — collagen in a tendon, an enzyme in your digestive tract, an appetite hormone in your brain — is a long chain of amino acids folded into a three-dimensional shape. A peptide is a much shorter version of that idea: sometimes only three or four amino acids linked together, sometimes fifteen or thirty. Short chains like these can be chemically synthesized in a laboratory, and their small, specific shape lets them slot into particular receptors on cell surfaces, acting like a key in a lock.

A research peptide is one that has been synthesized and studied — in cell cultures, in animal models, or occasionally in early human trials — but has not been approved by a drug regulator as a medicine. For the purposes of this desk, that framing matters a great deal: it tells you immediately whether the compound has cleared the bar of regulatory review or is still working through it. Semaglutide on this desk is an approved medicine with large trials behind it. Ipamorelin and BPC-157 are not approved and remain research-stage. GHK-Cu sits in a third category: a well-established cosmetic ingredient with a legal topical track record but no approved injectable or systemic indication.

Whenever this desk reports a finding, it reports it the way the underlying study did — studied at dose X in species Y — never as a recommendation.

How these four peptides fit the research-fundamentals map

The four compounds on this desk were chosen because they illuminate different corners of peptide biology — and because understanding them together gives you a much clearer map than reading any one in isolation.

• BPC-157 — Body Protection Compound 157 — is a synthetic 15-amino-acid peptide derived from a protein in gastric juice. Its repair effects in animal models are tied most consistently to angiogenesis (new blood-vessel formation), particularly through the VEGFR2 pathway ^[4]. It has been studied in rodent models of tendon, muscle, gut, and nerve injury, with only a handful of small human pilot reports ^[2].
• Ipamorelin is the lead of this desk. It is a synthetic pentapeptide (five amino acids) and a selective agonist of the ghrelin receptor (GHS-R1a). When it binds that receptor on pituitary cells, it triggers a pulse of growth hormone (GH) release without meaningfully raising cortisol or prolactin — which is its defining pharmacological feature ^[11]. It was the first GH secretagogue described as truly selective in that way. Never approved as a drug.
• Semaglutide is a long-acting analogue of the incretin hormone GLP-1. It is the most clinically established compound on this desk: FDA-approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction, and (in 2025) metabolic liver disease ^[15][16]. It is the only member of this group with phase 3 trial data and a regulatory track record.
• GHK-Cu is a copper-binding tripeptide (Gly-His-Lys coordinated with a Cu(II) ion) that occurs naturally in human plasma. It stimulates fibroblasts to produce collagen and elastin and may modulate a wide range of gene expression in tissue-repair pathways ^[19]. Most human evidence is from small topical skin trials ^[18][21].

Together they map four distinct biological territories: blood supply and tissue repair, growth-hormone signaling, metabolic and cardiovascular regulation, and skin matrix biology. Compare these peptides side by side, or dive into each one directly.

How this desk reads the literature

Peptide Download is a cross-referenced literature digest. Each compound page summarizes peer-reviewed studies for that molecule, cites them by number, and the citations link back to the full reference list where you can find DOIs, PubMed IDs, and journal details for every source.

Where evidence is thin, preliminary, single-lab, or entirely preclinical, the desk says so plainly. That degree of honesty about uncertainty is not a caveat tacked on at the end — it is the point. The difference between 'studied in rats' and 'demonstrated in replicated human trials' is the most important piece of information on any given page. Our editorial method: present the claim, name the species and study design, cite the source, note the limitations. No hype, no hedge that buries the finding, no dose recommendations.